$5.07
-0.28-5.23%
At close: -
$4.84
-0.23-4.54%
After Hours: 4:37 PM EDT
Comments
Loading...
Fulcrum Therapeutics Stock Guidance | NASDAQ:FULC | Benzinga
Fulcrum Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics Inc (FULC) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Fulcrum Therapeutics (FULC)?
There have been no specific sales or earnings guidance reported for Fulcrum Therapeutics in recent months.
Browse guidance and forecast on all stocks.
